For research use only. Not for therapeutic Use.
AV023 is a potent inhibitor of ANKRD22. AV023 promotes the expansion of gastrointestinal mucosal epithelial stem cells and indirectly activates the Wnt classical pathway, which helps the recovery of damaged gastrointestinal mucosal tissues in the body (extracted from patent CN111205231B)[1].
| Catalog Number | I044007 |
| CAS Number | 1107710-62-2 |
| Synonyms | N-cyclohexyl-3-[3-[4-(2-ethoxyethoxy)phenyl]-5-oxo-4H-1,2,4-triazin-6-yl]propanamide |
| Molecular Formula | C22H30N4O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H30N4O4/c1-2-29-14-15-30-18-10-8-16(9-11-18)21-24-22(28)19(25-26-21)12-13-20(27)23-17-6-4-3-5-7-17/h8-11,17H,2-7,12-15H2,1H3,(H,23,27)(H,24,26,28) |
| InChIKey | PRBZQYGBPDJGLE-UHFFFAOYSA-N |
| SMILES | CCOCCOC1=CC=C(C=C1)C2=NN=C(C(=O)N2)CCC(=O)NC3CCCCC3 |
| Reference | [1]. Yongquan Zhu, et al. Lead compounds as ankrd22 inhibitors and their applications. Patent CN111205231B. |
